Chaoqun Liu
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Tumor-secreted dentin sialophosphoprotein induces oxaliplatin resistance in colorectal cancer through an integrin αvβ3-dependent pathway
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: March 26, 2026
Targeting SLC5A2 suppresses colorectal tumour development by enhancing NK cell activity through extracellular vesicle-dependent MICA/B signalling.
Journal: Clinical and translational medicine
Published: December 09, 2025
Corrigendum to "Spatial Evaluation and Prognostic Significance of V-Domain Immunoglobulin Suppressor of T-Cell Activation (VISTA) in Human Resectable Cervical Carcinoma: Implications for Immune Activation and Suppression" [Modern Pathology 2025;38(12):100851].
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: October 08, 2025
Neutralizing dentin sialophosphoprotein facilitates tumor vascular normalization in colorectal cancer by blocking the crosstalk between tumor cells and endothelial cells.
Journal: Acta pharmaceutica Sinica. B
Published: April 12, 2025
Spatial Evaluation and Prognostic Significance of V-Domain Immunoglobulin Suppressor of T-Cell Activation (VISTA) in Human Resectable Cervical Carcinoma: Implications for Immune Activation and Suppression.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: February 18, 2025
Targeting Werner Helicase: A novel combination strategy for MSI colorectal cancer.
Journal: Biochemical pharmacology
Published: January 14, 2025
Inhibition of CCT5-mediated asparagine biosynthesis and anti-PD-L1 produce synergistic antitumor effects in colorectal cancer.
Journal: Acta pharmaceutica Sinica. B
Published: December 15, 2024
HTRA1 interacts with SLC7A11 to modulate colorectal cancer chemosensitivity by inhibiting ferroptosis.
Journal: Cell death discovery
Published: January 12, 2024
Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy.
Journal: Frontiers in immunology
Published: September 09, 2023
Targeting N6-methyladenosine RNA modification combined with immune checkpoint Inhibitors: A new approach for cancer therapy.
Journal: Computational and structural biotechnology journal
Published: June 15, 2022
Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker.
Journal: Frontiers in cell and developmental biology
Published: May 27, 2022
Last Updated: 09/26/2026